North America Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026
The North America Fusion Biopsy Market would witness market growth of 10.7% CAGR during the forecast period (2020-2026).
A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
The factors that drive the growth of the Fusion Biopsy System Market comprise the rising demand, increasing cancer disorders, changes brought into the standard of living, a more sedentary lifestyle, and at the same time increasing awareness among people. Fusion Biopsy System Market is further characterized
Based on geography and applications. On the basis of End Use, Fusion Biopsy System Market is categorized into Hospitals, Diagnostic Centers, and Ambulatory Surgical Center (ASCs).
The government initiatives are also increasing in terms of spreading awareness, funding research, and conducting mass screening programs that are related to prostate cancer therefore they are predicted to play a vital role in the growth of the fusion biopsy market. For example, the U.S. federal government is investing millions of dollars annually in prostate cancer research from the Prostate Cancer Research Program (PCRP), and the National Institute of Health (NIH). The venture is made to progress the advancement in prostate cancer care, its diagnostic and treatment technologies.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
The factors that drive the growth of the Fusion Biopsy System Market comprise the rising demand, increasing cancer disorders, changes brought into the standard of living, a more sedentary lifestyle, and at the same time increasing awareness among people. Fusion Biopsy System Market is further characterized
Based on geography and applications. On the basis of End Use, Fusion Biopsy System Market is categorized into Hospitals, Diagnostic Centers, and Ambulatory Surgical Center (ASCs).
The government initiatives are also increasing in terms of spreading awareness, funding research, and conducting mass screening programs that are related to prostate cancer therefore they are predicted to play a vital role in the growth of the fusion biopsy market. For example, the U.S. federal government is investing millions of dollars annually in prostate cancer research from the Prostate Cancer Research Program (PCRP), and the National Institute of Health (NIH). The venture is made to progress the advancement in prostate cancer care, its diagnostic and treatment technologies.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
- Transperineal
- Transrectal
- US
- Canada
- Mexico
- Rest of North America
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Fusion Biopsy Market, by End Use
1.4.2 North America Fusion Biopsy Market, by Route
1.4.3 North America Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. NORTH AMERICA FUSION BIOPSY MARKET BY END USES
4.1 North America Diagnostic centers Market by Country
4.2 North America Hospitals Market by Country
4.3 North America Ambulatory care centers Market by Country
CHAPTER 5. NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE
5.1 North America Transperineal Market by Country
5.2 North America Transrectal Market by Country
CHAPTER 6. NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY
6.1 USA Fusion Biopsy Market
6.1.1 USA Fusion Biopsy Market by End Uses
6.1.2 USA Fusion Biopsy Market by Route
6.2 Canada Fusion Biopsy Market
6.2.1 Canada Fusion Biopsy Market by End Users
6.2.2 Canada Fusion Biopsy Market by Route
6.3 Mexico Fusion Biopsy Market
6.3.1 Mexico Fusion Biopsy Market by End Users
6.3.2 Mexico Fusion Biopsy Market by Route
6.4 Rest of North America Fusion Biopsy Market
6.4.1 Rest of North America Fusion Biopsy Market by End Users
6.4.2 Rest of North America Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Fusion Biopsy Market, by End Use
1.4.2 North America Fusion Biopsy Market, by Route
1.4.3 North America Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. NORTH AMERICA FUSION BIOPSY MARKET BY END USES
4.1 North America Diagnostic centers Market by Country
4.2 North America Hospitals Market by Country
4.3 North America Ambulatory care centers Market by Country
CHAPTER 5. NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE
5.1 North America Transperineal Market by Country
5.2 North America Transrectal Market by Country
CHAPTER 6. NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY
6.1 USA Fusion Biopsy Market
6.1.1 USA Fusion Biopsy Market by End Uses
6.1.2 USA Fusion Biopsy Market by Route
6.2 Canada Fusion Biopsy Market
6.2.1 Canada Fusion Biopsy Market by End Users
6.2.2 Canada Fusion Biopsy Market by Route
6.3 Mexico Fusion Biopsy Market
6.3.1 Mexico Fusion Biopsy Market by End Users
6.3.2 Mexico Fusion Biopsy Market by Route
6.4 Rest of North America Fusion Biopsy Market
6.4.1 Rest of North America Fusion Biopsy Market by End Users
6.4.2 Rest of North America Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 4 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 5 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 USA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 USA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 USA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 USA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 USA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 USA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 CANADA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 CANADA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 CANADA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 28 CANADA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 29 CANADA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 CANADA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 MEXICO FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 MEXICO FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 MEXICO FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 34 MEXICO FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 35 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 36 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 40 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 41 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 44 KEY INFORMATION – HITACHI, LTD.
TABLE 45 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 46 KEY INFORMATION – ESAOTE SPA
TABLE 47 KEY INFORMATION – EIGEN
TABLE 48 KEY INFORMATION – KOELIS, INC.
TABLE 49 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 50 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
TABLE 1 NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 4 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 5 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 USA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 USA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 USA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 USA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 USA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 USA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 CANADA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 CANADA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 CANADA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 28 CANADA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 29 CANADA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 CANADA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 MEXICO FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 MEXICO FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 MEXICO FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 34 MEXICO FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 35 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 36 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 40 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 41 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 44 KEY INFORMATION – HITACHI, LTD.
TABLE 45 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 46 KEY INFORMATION – ESAOTE SPA
TABLE 47 KEY INFORMATION – EIGEN
TABLE 48 KEY INFORMATION – KOELIS, INC.
TABLE 49 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 50 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
